Encompass Health Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Encompass Health Corporation on May 14, 2026. The filing discloses the entry into a material definitive agreement regarding a private debt offering.
Key Financial Metrics and Transaction Details
- Debt Issuance: The Company entered into a purchase agreement for a private offering of $500,000,000 in aggregate principal amount of 5.875% senior notes due 2034.
- Closing Date: The offering is expected to close on or about May 29, 2026.
- Use of Proceeds: Net proceeds, combined with cash on hand, are intended to:
- Redeem at par $400 million of the Company's 4.500% Senior Notes due 2028 (outstanding principal: $800 million).
- Repay $100 million of outstanding amounts under the Company's revolving credit facility.
- Pay related fees and expenses.
- Underwriter: Wells Fargo Securities, LLC, as representative of the initial purchasers.
Material Changes
The filing does not report operational changes or historical financial performance metrics. The primary material change is the restructuring of the Company's debt profile through the issuance of new long-term notes to refinance existing senior notes and reduce revolver utilization.
Outlook, Risks, and Contingencies
The Notes are being offered in a transaction exempt from registration under the Securities Act of 1933, relying on Rule 144A and Regulation S. The filing includes standard forward-looking statements regarding the closing of the transaction and the use of proceeds. The Company notes that the Initial Purchasers and their affiliates have performed and may continue to perform commercial and investment banking services for the Company.
Investor Verification Checklist
- Verify the final closing date of the Notes Offering (expected May 29, 2026).
- Confirm the exact amount of cash on hand used in conjunction with the net proceeds for the debt redemption.
- Review the full text of the Purchase Agreement (Exhibit 10.1) for specific covenants and conditions to closing.
- Monitor the press release (Exhibit 99.1) for updated forward-looking statements and risk factors.